Neuralink Raises $600 Million, Valued at $9 Billion

San Francisco, CA — Neuralink, the brain-mapping company founded by Elon Musk, has secured $600 million in funding, raising its total valuation to $9 billion, according to sources familiar with the deal. This funding comes as the company has made significant advancements in developing brain-computer interface technology.

The latest infusion of cash follows a valuation of $3.5 billion recorded in late 2023. Neuralink, which had previously aimed to raise $500 million at a valuation of $8.5 billion, has successfully implanted brain chips in patients with paralysis and speech impairments. One notable case involves a non-verbal man with ALS, who demonstrated the technology’s capabilities by posting a message on Musk’s social media platform X.

Neuralink’s CEO, Jared Birchall, did not respond to requests for comment regarding the funding round. According to PitchBook data, the company had previously raised $280 million, led by Peter Thiel’s Founders Fund, and was estimated to be valued at around $5 billion in early 2023.

In addition to the recent funding, Neuralink received a “breakthrough” designation from the Food and Drug Administration earlier this month, expediting its technological evaluations.

Musk has expressed ambitious plans for the device, envisioning it as a solution not only for medical conditions like spinal cord injuries but also for treating obesity, autism, depression, and schizophrenia. He anticipates that future applications may even allow for telepathy and seamless internet navigation through thought alone.